HB484Introduced in the House of Delegates
Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising
Introduced by Natalie Ziegler, District 9
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Providing an addition modification under the corporate income tax for the amount of certain direct-to-consumer advertising expenses for certain covered drugs paid or incurred during the taxable year that are deducted under the Internal Revenue Code; and applying the Act to all taxable years beginning after December 31, 2025.
Where it stands
Hearing 2/12 at 1:00 p.m.
January 23, 2026
How did lawmakers vote?
No recorded vote is available for this bill yet.
Bill history
First Reading Ways and Means
Hearing 2/12 at 1:00 p.m.
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.